Aurobindo Pharma Receives FDA Approval for Generic Metformin Hydrochloride Tablets

by Kathy Jones on  July 24, 2012 at 8:20 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Hyderabad-based drugmaker Aurobindo Pharma announced that it has received approval from the US Food and Drug Administration to manufacture Metformin Hydrochloride extended release tablets for treating diabetes.
 Aurobindo Pharma Receives FDA Approval for Generic Metformin Hydrochloride Tablets
Aurobindo Pharma Receives FDA Approval for Generic Metformin Hydrochloride Tablets

The company revealed that it has received approval to market the drug in 500mg and 750mg strengths and will be manufactured in the Unit III formulations facility in Hyderabad which had been placed under an import ban by the FDA until recently due to the packaging facilities not being up to mark in terms of good manufacturing practices.

The ban was overturned back in March this year after inspections by the FDA, following which the health regulator has approved manufacture of blood thinner clopidogrel and psychiatric drug Quetiapine.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Metformin - Diabetes Drug with New Therapeutic Uses 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...